The Men's Health Summit 2024! The Complete Health Guide for Men and Women will be held at the Virginia Beach Oceanfront Hilton on Saturday, October 5, 2024. Topics will include all issues of the...

Today, the ELISA (Enabling Linux in Safety Applications) Project welcomes Hamburg University Technology - Institute of Aircraft Systems Engineering and Lynx Software Technologies to its ecosystem....

ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder...

Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease New results show potential of RYBREVANT® beyond lung cancer BARCELONA, Sept....

SmallRig recently showcased three innovative products at the IBC Show 2024 in the Netherlands. These cutting-edge releases are designed to revolutionize the way creators approach lighting and...

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE,...

Adela's tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & neck cancer, regardless of HPV status The test identified recurrences...

At RE+ 2024, Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring its leadership in providing end-to-end energy storage solutions. With 27 years of experience in...

Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2...

XCMG Machinery ("XCMG", SHE: 000425) is set to present its largest-ever collection of mining equipment at MinExpo 2024, taking place from September 24-26 in Las Vegas. Visitors can find XCMG at...